Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
-
Clinical Benefit
Insufficient
the Transparency Committee considers that the actual benefit of these proprietary medicinal products, in comparison with the treatments that are already available, is not sufficient to justify reimbursement by National Health Insurance.
Listen
